Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16545330 | 1.00 | CYP3A4 (0.39) | CYP3A4TSHRMAPK1TDP1TRPA1 | |
| SCHEMBL16186419 | 0.93 | CYP3A4 (0.34) | CYP3A4TSHRTRPA1 | |
| SCHEMBL34741 | 0.89 | CYP3A4 (0.47) | CYP3A4TSHRMAPK1TDP1TRPA1 | |
| SCHEMBL12908787 | 0.87 | TSHR (0.37) | CYP3A4TSHRMAPK1TDP1TRPA1 | |
| SCHEMBL25873141 | 0.87 | CYP3A4 (0.37) | CYP3A4TSHRMAPK1TDP1TRPA1 | |
| SCHEMBL13084705 | 0.86 | CYP3A4 (0.36) | CYP3A4TSHRMAPK1TDP1 | |
| SCHEMBL10033172 | 0.84 | CYP3A4 (0.42) | CYP3A4TSHRMAPK1TDP1TRPA1 | |
| SCHEMBL15981020 | 0.84 | CYP3A4 (0.42) | CYP3A4TSHRMAPK1TDP1TRPA1 | |
| SCHEMBL25873160 | 0.83 | CYP3A4 (0.34) | CYP3A4TSHRTRPA1 | |
| SCHEMBL25873163 | 0.83 | CYP3A4 (0.34) | CYP3A4TSHRTRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9840701-B2 | Porous membrane having immobilized enzyme, porous membrane composite including the same, and preparation method thereof | GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2017-12-12 | — | — | US | disclosed |
| US-20170101660-A1 | ENZYME-IMMOBILIZED POROUS MEMBRANE AND PREPARATION METHOD OF ANTIBIOTICS USING THE SAME | GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2017-04-13 | — | — | US | disclosed |
| US-20160348090-A1 | POROUS MEMBRANE HAVING IMMOBILIZED ENZYME, POROUS MEMBRANE COMPOSITE INCLUDING THE SAME, AND PREPARATION METHOD THEREOF | GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2016-12-01 | — | — | US | disclosed |
| US-20150099288-A1 | POROUS MEMBRANE HAVING IMMOBILIZED ENZYME, POROUS MEMBRANE COMPOSITE INCLUDING THE SAME, AND PREPARATION METHOD THEREOF | GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2015-04-09 | — | — | US | disclosed |
| US-20150059579-A1 | GAS SEPARATION MEMBRANE FOR CARBON DIOXIDE AND PREPARATION METHOD THEREOF | GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2015-03-05 | — | — | US | disclosed |
| US-8815967-B2 | Porous polyurea material and methods for preparing the same | Gwangju Institute of Science an Technology (KR) | 2014-08-26 | — | — | US | disclosed |
| US-20120095123-A1 | POROUS POLYUREA MATERIAL AND METHODS FOR PREPARING THE SAME | GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2012-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170101660-A1 | ENZYME-IMMOBILIZED POROUS MEMBRANE AND PREPARATION METHOD OF ANTIBIOTICS USING THE SAME | ADA, ANPEP, PEPD | CYP3A4 360/4885TSHR 2997/4885MAPK1 4231/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.